Vanadate-induced nitric oxide production: Role in osteoblast growth and differentiation

European Journal of Pharmacology

Volumn 400, Issue 2-3, 2000, Pages 279-285

  Cortizo, Ana M ^a   Caporossi, Mariana ^a   Lettieri, Gabriela ^a   Etcheverry, Susana B ^a  

^a UNIVERSIDAD NACIONAL DE LA PLATA   (Argentina)

Author keywords

Bone; Cytotoxicity; Growth; Nitric oxide (NO); Nitric oxide (NO) synthases; Osteoblast differentiation; Vanadium

Indexed keywords

ALKALINE PHOSPHATASE; CALCIMYCIN; EGTAZIC ACID; ISOENZYME; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; VANADIC ACID;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL LINE; CONTROLLED STUDY; CULTURE MEDIUM; DOSE RESPONSE; ENZYME ACTIVITY; IMMUNOBLOTTING; IN VITRO STUDY; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; RAT;

ALKALINE PHOSPHATASE; ANIMALS; CALCIUM; CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; CULTURE MEDIA; MICE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; NITROPRUSSIDE; OSTEOBLASTS; RATS; VANADATES; VASODILATOR AGENTS;

EID: 0034698240     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00356-3     Document Type: Article

References (37)

1. Armour K.E., Ralston S.H. Estrogen upregulates endothelial constitutive nitric oxide synthase expression in human osteoblast-like cells. Endocrinology. 139:1998;799-802.
2. Barrio D.A., Braziunas M.D., Etcheverry S.B., Cortizo A.M. Maltol complexes of vanadium(IV) and (V) regulate the alkaline phosphatase activity and the osteoblast-like cell growth. J. Trace Elem. Med. Biol. 11:1997;110-115.
3. Bradford M. Rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
4. Chae H.J., Park R.K., Chung H.T., Kang J.S., Kim M.S., Choi D.Y., Bang B.G., Kim H.R. Nitric oxide is a regulator of bone remodelling. J. Pharm. Pharmacol. 49:1997;897-902.
5. Cohen N., Halberstam M., Shlimovich P., Chang C.J., Shamoon H., Rossetti L. Oral vanadyl sulfate improves hepatic and peripheral sensitivity in patients with non-insulin-dependent diabetes mellitus. J. Clin. Invest. 95:1995;2501-2509.
6. Cortizo A.M., Etcheverry S.B. Vanadium derivatives act as growth factor-mimetic compounds upon differentiation and proliferation of osteoblast-like UMR106 cells. Mol. Cell. Biochem. 145:1995;97-102.
7. Cusi K., Cukier S., Defronzo R., Torres M. Metabolic effects of treatment with vanadyl sulfate in NIDDM. Diabetes. 46(1):1997;34A.
8. Damoulis P.D., Hauschka P.V. Nitric oxide act in conjunction with proinflammatory cytokines to promote cell death in osteoblasts. J. Bone Miner. Res. 12:1997;412-422.
9. Danziger R.S., Zuckerbraum B.S., Pensler J.M. Role of nitric oxide in the regulation of osteoblast metabolism. Plast. Reconstr. Surg. 100:1997;670-673.
10. Docena G.H., Benítez P., Campos R.E., Macia A., Fernández R., Fossati C.A. Detection of allergens in Aedes albifasciatus mosquito (Diptera: Culicidae) extracts by immunological methods. Invest. Allergol. Clin. Immunol. 9:1999;165-171.
11. Domingo J.L. Vanadium: a review of the reproductive and developmental toxicity. Reprod. Toxicol. 10:1996;175-182.
12. Etcheverry S.B., Cortizo A.M. Bioactivity of vanadium compounds on cells in culture. Nriagu J.O. Vanadium in the Environment. 1998;359-394 Wiley, New York.
13. Etcheverry S.B., Crans D.C., Keramidas A.D., Cortizo A.M. Insulin-mimetic action of vanadium compounds on osteoblast-like cells in culture. Arch. Biochem. Biophys. 338:1997;7-14.
14. Fox S.W., Chow J.W.M. Nitric oxide synthase expression in bone cells. Bone. 23:1998;1-6.
15. Goldfine A.B., Simonson D.C., Folli F., Patti M.E., Kahn C.R. Metabolic effects of sodium metavanadate in humans with insulin-dependent and noninsulin-dependent diabetes mellitus in vivo and in vitro studies. J. Clin. Endocrinol. Metab. 80:1995;3311-3320.
16. Green L.C., Wagner D.A. Analysis of nitrate, nitrite, and (15N)nitrate in biological fluids. Anal. Biochem. 126:1982;131-138.
17. Gresser M.J., Tracey A.S. Vanadate as phosphate analogs in biochemistry. Chasteen N.D. Vanadium in Biological Systems. 1990;63-79 Kluwer Academic Publishing, Netherlands.
18. Halberstam M., Cohen H., Shlimovich P., Rossetti L., Shamoon H. Oral vanadyl sulfate improves insulin sensitivity in NIDDM but not in obese nondiabetic subjects. Diabetes. 45:1996;659-666.
19. Helfrich M.H., Evans D.E., Grabowski P.S., Pollock J.S., Ohshima H., Ralston S.H. Expression of nitric oxide synthase isoforms in bone and bone cell cultures. J. Bone Miner. Res. 12:1997;1108-1115.
20. Hikiji H., Shin W.S., Oida S., Takato T., Koizumi T., Toyo-oka T. Direct action of nitric oxide on osteoblastic differentiation. FEBS Lett. 410:1997;238-242.
21. Hukkanen M.V., Platts L.A.M., Fernandez de Marticorena I., O'Shaughnessy M., Macintyre I., Polak J.M. Developmental regulation of nitric oxide synthase expression in rat skeletal bone. J. Bone Miner. Res. 14:1999;868-877.
22. Laemmli E.K. Cleavage of structural protein during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
23. Lowry O.H., Rosebrough N.J., Farr A.J., Randall R.J. Protein measurement with Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
24. McCarthy I.D., Andhoga M., Batten J.J., Mathie R.T. Endothelium-dependent vasodilatation produced by the L-arginine/nitric oxide pathway in normal and ischemic bone. Acta Orthop. Scand. 68:1997;361-368.
25. Nakaike R., Shimokawa H., Owada M.K., Tokunaga O., Yasutake H., Kishimoto T., Imada C., Shiraishi T., Egashira K., Takeshita A. Vanadate causes synthesis of endothelium-derived NO via pertussis toxin-sensitive G protein in pigs. Am. J. Physiol. 271:1996;H296-H302.
26. Nriagu J.O. History, occurrence, and uses of vanadium. Nriagu J.O. Vanadium in the Environment. 1998;1-24 Wiley, New York.
27. Okajima T., Nakamura K., Zhang H., Ling N., Tanabe T., Yasuda T., Rosenfeld R.G. Sensitive colorimetric bioassay for insulin-like growth factor (IGF) stimulation of cell proliferation and glucose consumption: Use in studies of IGF analogs. Endocrinology. 130:1992;2201-2212.
28. Ralston S.H. Nitric oxide and bone: what a gas! Br. J. Rheumatol. 36:1997;831-838.
29. Ralston S.H., Todd D., Helfrich M., Benjamin N., Grabowski P.S. Human osteoblast-like cells produce nitric oxide and express inducible nitric oxide synthase. Endocrinology. 135:1994;330-336.
30. Sabbioni E., Pozzi G., Devos S., Pintar A., Casella L., Fischbach M. The intensity of vanadium(V)-induced biotoxicity and morphological transformation in BALB/3T3 cells independent on gluthatione-mediated biorreduction to vanadium(IV). Carcinogenesis. 14:1993;2565-2568.
31. Sálice V.C., Cortizo A.M., Gómez Dumm C.L., Etcheverry S.B. Tyrosine phosphorylation and morphological transformation induced by four vanadium compounds on MC3T3E1 cells. Mol. Cell. Biochem. 198:1999;119-128.
32. Shechter Y. Insulin-mimetic effect of vanadate. Possible implications for future treatment of diabetes. Diabetes. 39:1990;1-5.
33. Shishodia S., Sodhi A., Shrivastava A. Cisplatin-induced activation of murine bone marrow-derived macrophages require protein tyrosine phosphorylation. Int. J. Immunopharmacol. 19:1997;683-690.
34. Stein G.S., Lian J.B. Molecular mechanism mediating proliferation/differentiation interrelationships during progressive development of the osteoblast phenotype. Endocr. Rev. 14:1993;424-442.
35. Sudo H., Kodama H.A., Amagai Y., Yamamoto S., Kasai S. In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria. J. Cell Biol. 96:1983;191-198.
36. Togari A., Arai M., Mogi M., Kondo A., Nagatsu T. Coexpression of GTP cyclohydrolase I and inducible nitric oxide synthase mRNAs in mouse osteoblastic cells activated by proinflammatory cytokines. FEBS Lett. 428:1998;212-216.
37. Van't Hof R.J., Ralston S.H. Cytokine-induced nitric oxide inhibits bone resorption by inducing apoptosis of osteoclast progenitors and suppressing osteoclast activity. J. Bone Miner. Res. 12:1997;1797-1804.